Phase 2 Dystrophic Epidermolysis Bullosa Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 1Phase 2
Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa
Recessive dystrophic epidermolysis bullosaEpidermolysis BullosaDystrophic Epidermolysis Bullosa+1 more
M. Peter Marinkovich8 enrolled1 locationNCT06834035
Recruiting
Phase 1Phase 2
GMEB-SASS: A Gene-Modified Skin Substitute for RDEB Treatment
Recessive dystrophic epidermolysis bullosaEpidermolysis Bullosa Dystrophica, RecessiveRDEB
CHU de Quebec-Universite Laval9 enrolled1 locationNCT07193134
Recruiting
Phase 2
A Phase 2 Study of TCP-25 Gel in Patients With Epidermolysis Bullosa, STEP-study
Dystrophic Epidermolysis BullosaEpidermolysis Bullosa (EB)Junctional Epidermolysis Bullosa
Xinnate AB32 enrolled6 locationsNCT06594393
Recruiting
Phase 1Phase 2
Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa
Wound HealDystrophic Epidermolysis Bullosa
Isfahan University of Medical Sciences20 enrolled1 locationNCT07230223
Recruiting
Phase 1Phase 2
MSC EVs in Dystrophic Epidermolysis Bullosa
Dystrophic Epidermolysis Bullosa
Aegle Therapeutics8 enrolled3 locationsNCT04173650
Recruiting
Phase 2
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa
Dystrophic Epidermolysis Bullosa
Anterogen Co., Ltd.6 enrolled1 locationNCT05157958
Completed
Phase 2
Investigation of cell therapy for recessive dystrophic epidermolysis bullosa (RDEB) in Australia through intradermal injection of allogeneic fibroblasts.
Recessive dystrophic epidermolysis bullosa
Research Infrastructure Support Services (RISS)5 enrolled1 locationACTRN12610000760077